Dexcom (DXCM) Change in Acquisitions & Divestments (2016 - 2025)
Dexcom (DXCM) has disclosed Change in Acquisitions & Divestments for 16 consecutive years, with $409.6 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 1.09% to $409.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, down 23.36% year-over-year, with the annual reading at $2.2 billion for FY2025, 23.36% down from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $409.6 million at Dexcom, down from $466.2 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $1.1 billion in Q1 2024, with the low at $241.8 million in Q1 2022.
- Average Change in Acquisitions & Divestments over 5 years is $636.5 million, with a median of $644.4 million recorded in 2025.
- The sharpest move saw Change in Acquisitions & Divestments plummeted 69.39% in 2022, then skyrocketed 188.5% in 2023.
- Over 5 years, Change in Acquisitions & Divestments stood at $501.0 million in 2021, then surged by 47.7% to $740.0 million in 2022, then dropped by 2.84% to $719.0 million in 2023, then plummeted by 43.64% to $405.2 million in 2024, then increased by 1.09% to $409.6 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $409.6 million, $466.2 million, and $638.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.